References
- AndersonGMScahillLMcCrackenJTEffects of short- and long-term risperidone treatment on prolactin levels in children with autismBiol Psychiatry2007615455016730335
- AmanMGManagement of hyperactivity and other acting-out problems in patients with autism spectrum disorderSemin Pediatr Neurol200411225815575418
- AmanMGSinghNNStewartAWThe aberrant behavior checklist: A behavior rating scale for the assessment of treatment effectsAm J Ment Defic198589485913993694
- AmanMGTasséMJRojahnJThe Nisonger CBRF: A child behavior rating form for children with developmental disabilitiesRes Dev Disabil19961741578750075
- [APA] American Psychiatric AssociationPervasive developmental disordersDiagnostic and Statistic Manual of Mental Disorders19944Washington, DCAmerican Psychiatric Association
- ArnoldLEVitielloBMcDougleCParent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trialsJ Am Acad Child Adolesc Psychiatry20034214435014627879
- BarnardLYoungAHPearsonJA systematic review of the use of atypical antipsychotics in autismJ Psychopharmacol2002169310111949778
- CampbellMArmenterosJLMaloneRPNeuroleptic-related dyskinesias in autistic children: a prospective longitudinal studyJ Am Acad Child Adolesc Psychiatry199736835439183140
- CampbellMRapoportJSimpsonGAntypsychotics in children and adolescentsJ Am Acad Child Adolesc Psychiatry1999385374510230185
- CanitanoRSelf injurious behavior in autism. Clinical aspects and treatment with risperdoneJ Neural Trans200611342531
- ChavezBChavez-BrownMReyJARole of risperidone in children with autism spectrum disorderAnn Pharmacother2006409091616684811
- DilerRSFiratSAvciAAn open label trial of risperidone in young children with autismCurr Ter Res Clin Exp20026391102
- FindlingRKusumakarVDanemanDProlactin levels during long-term risperidone treatment in children and adolescentsJ Clin Psychiatry2003641362914658952
- FismanSSteeleMRisperidone in pervasive developmental disorders: a case seriesJ Child Adolesc Psychopharmacol19966177909231311
- FombonneEEpidemiology of autistic disorder and other pervasive developmental disordersJ Clin Psychiatry200566S103816401144
- GaglianoAGermanoEPustorinoGRisperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implicationsJ Child Adolesc Psychopharmacol200414394715142390
- JesnerOAref-AdibMCorenERisperidone for autism spectrum disorderCochrane Database Syst Rev200724CD00504017253538
- LubyJMrakotskyCStaletsMMRisperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacyJ Child Adolesc Psychopharmacol2006165758717069546
- MaloneRPMaislinGChoudhuryMSRisperidone treatment in children and adolescents with autism: Short- and long-term safety and effectivenessJ Am Acad Child Adolesc Psychiatry200241140711837403
- MasiGCosenzaAMucciMOpen trial of risperidone in 24 young children with pervasive developmental disordersJ Am Acad Child Adolesc Psychiatry20014012061411589534
- MasiGCosenzaAMucciMA 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidoneJ Clin Psychiatry20036410394714628979
- McCrackenJTMcGoughJShahBResearch Units on Pediatric Psychopharmacology Autism NetworkRisperidone in children with autism and serious behavioral problemsN Engl J Med20023473142112151468
- McDougleCHolmesJBronsonMRRisperidone treatment in children and adolescent with pervasive developmental disorders: A prospective open-label trialJ Am Acad Child Adolesc Psychiatry199736685939136504
- McDougleCJScahillLAmanMGRisperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacologyAm J Psychiatry20051621142815930063
- NagarajRSinghiPMalhiPRisperidone in children with autism: randomized, placebo-controlled, double-blind studyJ Child Neurology2006214505
- NicolsonRAwadGSlomanLAn open trial of risperidone in young autistic childrenJ Am Acad Child Adolesc Psychiatry19983737269549957
- PandinaGJBossieCAYoussefERisperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trialJ Autism Dev Disord2007373677317019624
- RauschJLSirotaELLondinoDLOpen-label risperidone for Asperger’s disorder: negative symptom spectrum responseJ Clin Psychiatry2005661592716401163
- [RUPPAN] Research Units on Pediatric Psychopharmacology Autism NetworkRisperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 monthsAm J Psychiatry20051621361915994720
- SchoplerEReichlerRJDeVellisRFToward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)J Autism Dev Disord198010911036927682
- SheaSTurgayACarrollARisperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disordersPediatrics2004114e634e64115492353
- TroostPWLahuisBESteenhuisMPLong-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation studyJ Am Acad Child Adolesc Psychiatry20054411374416239862
- WestLWaldropJRisperidone use in the treatment of behavioral symptoms in children with autismPediatr Nurs200632545917256292
- ZuddasADi MartinoAMugliaPLong-term risperidone for pervasive developmental disorder: efficacy, tolerability and discontinuationJ Child Adolesc Psychopharmacol200010799010933118